MOLN

MKT CAP:$158M

Molecular Partners AG ADR

Market Cap

$158M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.10-$0.12 (-2.84%)

Jun 5, 2026

52W High $5.1352W Low $3.47

Company Details

Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phas...

CEO

—

IPO Date

Jun 16, 2021

Website

www.molecularpartners.com

Key Metrics TTM (CHF)

Revenue

CHF 0

-100.0% YoY

Net Income

-CHF 72M

EPS (Diluted)

Free Cash Flow

-CHF 54M

Revenue / Share

CHF 0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

CHF 0

FY 2025

Mar 12, 2026

CHF 0-100.0%

Q4 2025

Mar 12, 2026

CHF 0

Q3 2025

Oct 30, 2025

CHF 0-100.0%

Q2 2025

Aug 25, 2025

CHF 0-100.0%

Revenue & Profitability (CHF)

Operating Cash Flow (CHF)

CapEx Spend (CHF)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CHF)

OpEx Breakdown (CHF)

War Chest (CHF)

Shares Outstanding

Revenue Per Employee (CHF)

Revenue / Employee